Back to search

Aristotle University Of Thessaloniki (AUTH)

Διερεύνηση διαγνωστικών και προγνωστικών δεικτών σε νεοπλασματικό παγκρεατικό ιστό μυών, με τη χορήγηση η μη χημειοθεραπευτικών: πειραματική μελέτη

Abstract

dc:description

ABSTRACTObjective Pancreatic cancer is one of the most aggressive tumors with less than 10% long-term survivors. The majority of cases are not surgically resectable at the time of diagnosis because of early metastasis and vascular invasion. The aim of our study was to investigate the diagnostic and prognostic value of tumor markers in pancreatic tumor bearing mice. Apart from the diagnostics markers which daily are used, several markers with prognostic interest are found such as Mesothelin, Cyclins, οι MMPs, Survivin, PCNA, P57kip2, Galectin 3, p21/Cip, IMP3 etc. Among the markers above mesothelin, survivin, CD171 and galectin-3 were selected for this study.Material and Methods Our study included 40 female C57 black mice, divided into 8 groups, in which pancreatic PAN-O2 tumor was subcutaneously implanted. In the first group the implanted tumor was resected at the 20th day (the first day at which tumor was palpable), where as in the second one the tumor was resected at the 30th day (day at which the size of tumor was maximum without necrosis). The third and fourth group of mice was given gemcitambine (Gemzar) and the implanted tumor was resected at the 20th and the 30th day respectively. Morever, the fifth and sixth group was given homo-aza-steroidal ester of p-bis (2-chloroethyl) amino phenylacetic acid (ASE) and the implanted tumor was resected at the 20th and the 30th day respectively. Finally, the rest two groups were given the combination of both chemotherapeutic agents and the implanted tumor was resected at the 20th and the 30th day respectively. Then, histological examination was followed. Moreover, FNA was performed and cytological samples were processed by ThinPrep method. On the specimens immuno-histo-cyto-chemistry was applied using a panel of tumor markers (mesothelin, galectin-3, survivin, CD-171). Results Tumor motion development results indicated significant statistic inhibition (p<0,01) in all groups in comparison with control group. Higher statistic inhibition was observed after the application of the composition of two chemotherapeutic agents comparing with separate application. Galectin-3 expression was higher at the early stages of developed tumor and lower at the 30th day. Mesothelin and Survivin high expression had a tendency to be at later stages of developed tumor. The nuclear Survivin overexpression was noted at the 20th while the cytoplasmic overexpression was detected at the 30th day. Chemotherapeutic agents application converted the marker expression in a variable pattern. Conclusions.The tumor markers mesothelin, survivin, CD171 and galectin-3 provide satisfactory information for the diagnosis and prognosis of pancreatic adenocarcinoma. Their application on histological and cytological material could contribute to the detection at the onset and the end of the disease and to follow up after chemotherapy.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kambas, Lambros
  • Καμπάς, Λάμπρος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/34562

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kambas, Lambros; Καμπάς, Λάμπρος. Διερεύνηση διαγνωστικών και προγνωστικών δεικτών σε νεοπλασματικό παγκρεατικό ιστό μυών, με τη χορήγηση η μη χημειοθεραπευτικών: πειραματική μελέτη. Aristotle University Of Thessaloniki (AUTH), 2014. http://hdl.handle.net/10442/hedi/34562